COLLEEN FOLKERS: Open Payments
NPI 1043597131 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$22,041 in 12 payments from 6 companies in 2025. Trend: 2023 $18,245 · 2024 $18,885 · 2025 $22,041
Consulting: $21,538Food & beverage: $503
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 4 | $21,575 |
| ABBVIE INC. | 2 | $169 |
| Novo Nordisk Inc | 2 | $102 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $74 |
| Ipsen Biopharmaceuticals, Inc | 2 | $68 |
| Madrigal Pharmaceuticals | 1 | $54 |
Products named: MAVYRET, XIFAXAN, IQIRVO, REZDIFFRA.
Industry payments across IL — which companies pay providers there.
